https://www.selleckchem.com/pr....oducts/ertugliflozin
86 (95% CI 0.80-0.91), and between TB disease from LTBI with an AUC of 0.88 (95% CI 0.82-0.93). CONCLUSION This gene signature accurately distinguishes early TB disease from those without TB disease or infection, in the context of community-wide TB screening. It could be used as a non-sputum based screening tool or triage test to detect prevalent cases of TB in the community. The phonemic merger is a unique phenomenon which is referred to as acoustically very different phonemes are recognized as the same phoneme. In our previous s
Curtir
Comentario
Compartilhar
